Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow

Details for Australian Patent Application No. 2006284513 (hide)

Owner Weiss, S.

Inventors Weiss, Steven Michael

Agent Steven Weiss

Pub. Number AU-A-2006284513

PCT Pub. Number WO2007/022568

Priority 2005904615 25.08.05 AU

Filing date 24 August 2006

Wipo publication date 1 March 2007

International Classifications

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/198 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/022568 Priority application(s): WO2007/022568

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284514-Ladder support

2006284512-Powder delivery nozzle